Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biocon Surges on $200 Million Payment From Pfizer for Biosimilar Insulin
Biocon Surges on $200 Million Payment From Pfizer for Biosimilar Insulin
Biocon Surges on $200 Million Payment From Pfizer for Biosimilar Insulin
Submitted by
admin
on October 19, 2010 - 9:17am
Source:
Bloomberg
News Tags:
Pfizer
Biocon
insulin
biosimilars
Headline:
Biocon Surges on $200 Million Payment From Pfizer for Biosimilar Insulin
Do Not Allow Advertisers to Use My Personal information
